Latest filing published 14 Aug 2026 for Orchestra BioMed Holdings, Inc., €20k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Eric S. Fain discloses dealings in Orchestra BioMed Holdings, Inc. to SEC (Form 4). The record holds 13 filings, for trades running from 26 January 2023 to 12 August 2026.
In open-market terms, that means 1 purchase worth €13k on one side and 2 sales worth €17k on the other. Netting one side against the other leaves €4,211 of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 8 share grants and 2 option exercises.
The record was last updated on 14 August 2026 with a share grant (€20k) in Orchestra BioMed Holdings, Inc. The most recent open-market purchase was published on 25 August 2025, 419 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations